ENXTPA:EDENDiversified Financial
Assessing Edenred (ENXTPA:EDEN) Valuation After Strong 2025 Beat And A Cautious 2026 Rebasing Year
Edenred (ENXTPA:EDEN) is back in focus after reporting 2025 results that topped its own guidance for EBITDA growth and free cash flow conversion, while management described 2026 as a rebasing year amid regulatory changes.
See our latest analysis for Edenred.
The recent earnings beat and confirmation of 2026 guidance have been met with a positive short term reaction, with a 1 day share price return of 3.93% and a 30 day share price return of 8.86%. However, the 1 year total shareholder return...